MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Abbott Laboratories

Closed

SectorHealthcare

128.47 1.01

Overview

Share price change

24h

Current

Min

128.47

Max

129.22

Key metrics

By Trading Economics

Income

454M

1.8B

Sales

784M

11B

P/E

Sector Avg

16.484

36.442

EPS

1.26

Dividend yield

1.75

Profit margin

15.967

Employees

114,000

EBITDA

383M

3B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+14.07% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.75%

3.00%

Next Dividend date

17 lis 2025

Market Stats

By TradingEconomics

Market Cap

-1B

229B

Previous open

127.46

Previous close

128.47

News Sentiment

By Acuity

57%

43%

296 / 371 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Abbott Laboratories Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

15 paź 2025, 12:02 UTC

Earnings

Abbott Labs Posts Higher 3Q Sales, Reaffirms Outlook

17 lip 2025, 12:10 UTC

Earnings

Abbott Labs Pares Outlook, Logs 2Q Profit Gains

15 paź 2025, 16:15 UTC

Earnings

Abbott Stock Drops Despite Earnings. Baby-Formula Sales Took a Hit. -- Barrons.com

15 paź 2025, 12:25 UTC

Earnings

Abbott Posts Solid Earnings, Adult Nutrition Drives Sales. The Stock Drops Anyway. -- Barrons.com

15 paź 2025, 11:32 UTC

Earnings

Abbott Labs Still Sees 2025 Organic Sales Up 6%-7% Including Covid-19 Testing-Related Sales >ABT

15 paź 2025, 11:32 UTC

Earnings

Abbott Labs Still Sees 2025 Organic Sales Up 7.5%-8% Excluding Covid-19 Testing-Related Sales >ABT

15 paź 2025, 11:31 UTC

Earnings

Abbott Labs Sees 2025 Adj EPS $5.12-Adj EPS $5.18 >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs 3Q Adjusted Operating Margin 23% >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs Reaffirms Full-Year Guidance >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs 3Q Organic Sales Growth Up 5.5% >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs 3Q Sales $11.37B >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs 3Q Adj EPS $1.30 >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs 3Q Net $1.64B >ABT

15 paź 2025, 11:30 UTC

Earnings

Abbott Labs 3Q EPS 94c >ABT

11 paź 2025, 00:18 UTC

Acquisitions, Mergers, Takeovers

Why Biotech May Be Back -- Barrons.com

17 lip 2025, 13:14 UTC

Earnings

Abbott Labs Stock Falls After Earnings. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 lip 2025, 12:16 UTC

Earnings

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 lip 2025, 11:32 UTC

Earnings

Abbott Labs Sees 3Q Adj EPS $1.28-Adj EPS $1.32 >ABT

17 lip 2025, 11:32 UTC

Earnings

Abbott Labs: See Momentum Carrying Into 2026 >ABT

17 lip 2025, 11:31 UTC

Earnings

Abbott Labs Sees 2025 Organic Sales Up 7.5%-8%, Excluding Covid-19 Testing-Related Sales >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Organic Sales Rose 6.9% >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Adjusted Operating Margin 22.9% >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Adjusted Gross Margin 57% >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Organic Sales Growth Up 6.9% >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Sales $11.14B >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Net $1.78B >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q Adj EPS $1.26 >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs Sees FY Adj EPS $5.10-Adj EPS $5.20 >ABT

17 lip 2025, 11:30 UTC

Earnings

Abbott Labs 2Q EPS $1.01 >ABT

17 lip 2025, 09:08 UTC

Hot Stocks

Stocks to Watch Thursday: TSMC, United Airlines, Sarepta -- WSJ

Peer Comparison

Price change

Abbott Laboratories Forecast

Price Target

By TipRanks

14.07% upside

12 Months Forecast

Average 146.63 USD  14.07%

High 162 USD

Low 136 USD

Based on 20 Wall Street analysts offering 12 month price targets forAbbott Laboratories - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

20 ratings

18

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

132.82 / 134.43Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

296 / 371 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat